Development and validation of a nomogram to predict cancer-specific survival of mucinous epithelial ovarian cancer after cytoreductive surgery

被引:4
|
作者
Ma, Guanchen [1 ,2 ]
Zeng, Shaoqing [1 ,2 ]
Zhao, Yingjun [1 ,2 ]
Chi, Jianhua [1 ,2 ]
Wang, Li [3 ]
Li, Qingshui [4 ]
Wang, Jing [5 ]
Yao, Shuzhong [6 ]
Zhou, Qi [7 ]
Chen, Youguo [8 ]
Jiao, Xiaofei [1 ,2 ]
Liu, Xingyu [1 ,2 ]
Yu, Yang [1 ,2 ]
Huo, Yabing [1 ,2 ]
Li, Ming [1 ,2 ]
Peng, Zikun [1 ,2 ]
Ma, Ding [1 ,2 ]
Hu, Ting [1 ,2 ]
Gao, Qinglei [1 ,2 ]
机构
[1] Huazhong Univ Sci & Technol, Tongji Hosp, Tongji Med Coll, Dept Gynecol Oncol, 1095 Jiefang Ave, Wuhan 430000, Peoples R China
[2] Huazhong Univ Sci & Technol, Tongji Hosp, Tongji Med Coll, Key Lab Minist Educ,Canc Biol Res Ctr,Natl Clin Re, Wuhan, Peoples R China
[3] Zhengzhou Univ, Canc Hosp, Henan Tumor Hosp, Dept Gynecol, Zhengzhou, Peoples R China
[4] Shandong Canc Hosp & Inst, Dept Gynecol Oncol, Jinan, Shandong, Peoples R China
[5] Cent South Univ, Affiliated Tumor Hosp, Dept Gynecol Oncol, Xiangya Sch Med, Changsha, Peoples R China
[6] Sun Yat Sen Univ, Affiliated Hosp 1, Dept Obstet & Gynecol, 58,2nd Zhongshan Rd, Guangzhou 510080, Peoples R China
[7] Chongqing Canc Hosp, Dept Gynecol Oncol, Chongqing 400030, Peoples R China
[8] Soochow Univ, Affiliated Hosp 1, Dept Obstet & Gynecol, Suzhou 215123, Peoples R China
基金
美国国家科学基金会;
关键词
Mucinous ovarian cancer; Nomogram; Cancer-specific survival; SEER database; RESIDUAL DISEASE;
D O I
10.1186/s13048-023-01213-2
中图分类号
Q [生物科学];
学科分类号
07 ; 0710 ; 09 ;
摘要
BackgroundMucinous epithelial ovarian cancer (mEOC) is a relatively uncommon subtype of ovarian cancer with special prognostic features, but there is insufficient research in this area. This study aimed to develop a nomogram for the cancer-specific survival (CSS) of mEOC based on Surveillance, Epidemiology, and End Results (SEER) database and externally validate it in National Union of Real World Gynecological Oncology Research and Patient Management (NUWA) platform from China.MethodsPatients screened from SEER database were allocated into training and internal validation cohort in a ratio of 7: 3, with those from NUWA platform as an external validation cohort. Significant factors selected by Cox proportional hazard regression were applied to establish a nomogram for 3-year and 5-year CSS. The performance of nomogram was assessed by concordance index, calibration curves and Kaplan-Meier (K-M) curves.ResultsThe training cohort (n = 572) and internal validation cohort (n = 246) were filtered out from SEER database. The external validation cohort contained 186 patients. Baseline age, tumor stage, histopathological grade, lymph node metastasis and residual disease after primary surgery were significant risk factors (p < 0.05) and were included to develop the nomogram. The C-index of nomogram in training, internal validation and external validation cohort were 0.869 (95% confidence interval [CI], 0.838-0.900), 0.839 (95% CI, 0.787-0.891) and 0.800 (95% CI, 0.738-0.862), respectively. The calibration curves of 3-year and 5-year CSS in each cohort showed favorable agreement between prediction and observation. K-M curves of different risk groups displayed great discrimination.ConclusionThe discrimination and goodness of fit of the nomogram indicated its satisfactory predictive value for the CSS of mEOC in SEER database and external validation in China, which implies its potential application in different populations.
引用
收藏
页数:10
相关论文
共 50 条
  • [21] Nomogram application to predict overall and cancer-specific survival in osteosarcoma
    Zheng, Weipeng
    Huang, Yuanping
    Chen, Haoyi
    Wang, Ning
    Xiao, Wende
    Liang, YingJie
    Jiang, Xin
    Su, Wenzhou
    Wen, Shifeng
    CANCER MANAGEMENT AND RESEARCH, 2018, 10 : 5439 - 5450
  • [22] Development and validation of a nomogram to predict cancer-specific survival for Asian/Pacific Islander patients with renal cell carcinoma
    Tang, Jie
    Wang, Jinkui
    Pan, Xiudan
    Zhang, Dianlong
    ASIAN JOURNAL OF SURGERY, 2023, 46 (08) : 3091 - 3093
  • [23] Prognostic Factors and a Predictive Nomogram of Cancer-Specific Survival of Epithelial Ovarian Cancer Patients with Pelvic Exenteration Treatment
    Wang, Ting
    Fu, Xin
    Zhang, Lei
    Liu, Shuna
    Tao, Ziqi
    Wang, Fang
    INTERNATIONAL JOURNAL OF CLINICAL PRACTICE, 2023, 2023
  • [24] Development and validation of a nomogram to predict overall survival of epithelial ovarian cancer patients: a population-based study
    Ma, Guanchen
    Zeng, Shaoqing
    Zhao, Yingjun
    Chi, Jianhua
    Wang, Li
    Li, Qingshui
    Wang, Jing
    Yao, Shuzhong
    Chen, Youguo
    Li, Huayi
    Li, Ruyuan
    Jiao, Xiaofei
    Liu, Xingyu
    Yu, Yang
    Huo, Yabing
    Li, Ming
    Peng, Zikun
    Ma, Ding
    Gao, Qinglei
    GYNECOLOGIC ONCOLOGY, 2022, 166 : S194 - S195
  • [25] Construction and validation of a nomogram based on the log odds of positive lymph nodes to predict cancer-specific survival in patients with small cell lung cancer after surgery
    Chao, Ce
    Mei, Kun
    Wang, Min
    Tang, Renzhe
    Qian, Yongxiang
    Wang, Bin
    Di, Dongmei
    HELIYON, 2023, 9 (08)
  • [26] Development and Validation of a Nomogram to Predict the Probability of Venous Thromboembolism in Patients with Epithelial Ovarian Cancer
    Wang, Yuhan
    Zhou, Haijian
    Zhong, Guanglei
    Fu, Zhaojie
    Peng, Yu
    Yao, Tingting
    CLINICAL AND APPLIED THROMBOSIS-HEMOSTASIS, 2022, 28
  • [27] Development and Validation of a Nomogram to Predict the Probability of Venous Thromboembolism in Patients with Epithelial Ovarian Cancer
    Wang, Yuhan
    Zhou, Haijian
    Zhong, Guanglei
    Fu, Zhaojie
    Peng, Yu
    Yao, Tingting
    CLINICAL AND APPLIED THROMBOSIS-HEMOSTASIS, 2022, 28
  • [28] Development and Validation of a Nomogram to Predict the Probability of Venous Thromboembolism in Patients with Epithelial Ovarian Cancer
    Wang, Yuhan
    Zhou, Haijian
    Zhong, Guanglei
    Fu, Zhaojie
    Peng, Yu
    Yao, Tingting
    CLINICAL AND APPLIED THROMBOSIS-HEMOSTASIS, 2022, 28
  • [29] Development and validation of a nomogram for predicting the cancer-specific survival of fibrolamellar hepatocellular carcinoma patients
    Hu, Jiawei
    Wang, Yi
    Deng, Liming
    Yu, Haitao
    Chen, Kaiyu
    Bao, Wenming
    Chen, Kaiwen
    Chen, Gang
    UPDATES IN SURGERY, 2022, 74 (05) : 1589 - 1599
  • [30] Development and validation of a nomogram to predict cancer-specific survival in middle-aged patients with papillary thyroid cancer: A SEER database study
    Tang, Jie
    Zhanghuang, Chenghao
    Yao, Zhigang
    Li, Li
    Xie, Yucheng
    Tang, Haoyu
    Zhang, Kun
    Wu, Chengchuang
    Yang, Zhen
    Yan, Bing
    HELIYON, 2023, 9 (02)